Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Conditions: Pituitary; Pituitary Tumor; Pituitary Carcinoma; Pituitary Cancer Interventions: Drug: Ipilimumab; Drug: Nivolumab Sponsor: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials